nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Epirubicin—thyroid cancer	0.267	0.519	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—thyroid cancer	0.247	0.481	CiPCiCtD
Irinotecan—lung cancer—thyroid cancer	0.244	1	CtDrD
Irinotecan—ABCC1—Vandetanib—thyroid cancer	0.0221	0.125	CbGbCtD
Irinotecan—UGT1A9—Sorafenib—thyroid cancer	0.0199	0.112	CbGbCtD
Irinotecan—UGT1A1—Sorafenib—thyroid cancer	0.0162	0.092	CbGbCtD
Irinotecan—ABCC1—Epirubicin—thyroid cancer	0.0152	0.0863	CbGbCtD
Irinotecan—ABCG2—Vandetanib—thyroid cancer	0.0148	0.0839	CbGbCtD
Irinotecan—ALB—Vandetanib—thyroid cancer	0.0102	0.0578	CbGbCtD
Irinotecan—ABCC2—Sorafenib—thyroid cancer	0.00988	0.0559	CbGbCtD
Irinotecan—ABCG2—Sorafenib—thyroid cancer	0.00893	0.0506	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—thyroid cancer	0.0081	0.0459	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0066	0.0374	CbGbCtD
Irinotecan—CYP3A7—Sorafenib—thyroid cancer	0.0066	0.0374	CbGbCtD
Irinotecan—CYP2B6—Sorafenib—thyroid cancer	0.00628	0.0356	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—thyroid cancer	0.006	0.0339	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—thyroid cancer	0.00542	0.0307	CbGbCtD
Irinotecan—CYP3A5—Sorafenib—thyroid cancer	0.00495	0.028	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—thyroid cancer	0.00381	0.0216	CbGbCtD
Irinotecan—ABCB1—Sorafenib—thyroid cancer	0.00322	0.0182	CbGbCtD
Irinotecan—CYP3A4—Vandetanib—thyroid cancer	0.0032	0.0181	CbGbCtD
Irinotecan—CES1—larynx—thyroid cancer	0.00217	0.183	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—thyroid cancer	0.00195	0.0111	CbGbCtD
Irinotecan—CYP3A4—Sorafenib—thyroid cancer	0.00193	0.0109	CbGbCtD
Irinotecan—CYP3A4—Doxorubicin—thyroid cancer	0.00117	0.00663	CbGbCtD
Irinotecan—TOP1MT—thyroid gland—thyroid cancer	0.000695	0.0588	CbGeAlD
Irinotecan—TOP1MT—head—thyroid cancer	0.000616	0.0521	CbGeAlD
Irinotecan—TOP1—saliva-secreting gland—thyroid cancer	0.000601	0.0508	CbGeAlD
Irinotecan—CES1—neck—thyroid cancer	0.000575	0.0486	CbGeAlD
Irinotecan—CES2—saliva-secreting gland—thyroid cancer	0.000545	0.0461	CbGeAlD
Irinotecan—TOP1—trachea—thyroid cancer	0.000463	0.0392	CbGeAlD
Irinotecan—TOP1MT—lymph node—thyroid cancer	0.000432	0.0365	CbGeAlD
Irinotecan—CES2—trachea—thyroid cancer	0.00042	0.0355	CbGeAlD
Irinotecan—TOP1—thyroid gland—thyroid cancer	0.000367	0.031	CbGeAlD
Irinotecan—CES2—thyroid gland—thyroid cancer	0.000332	0.0281	CbGeAlD
Irinotecan—SLC22A3—saliva-secreting gland—thyroid cancer	0.000311	0.0263	CbGeAlD
Irinotecan—CES2—head—thyroid cancer	0.000295	0.0249	CbGeAlD
Irinotecan—CES1—thyroid gland—thyroid cancer	0.000274	0.0232	CbGeAlD
Irinotecan—ACHE—thyroid gland—thyroid cancer	0.000274	0.0232	CbGeAlD
Irinotecan—CES1—head—thyroid cancer	0.000243	0.0205	CbGeAlD
Irinotecan—TOP1—lymph node—thyroid cancer	0.000228	0.0193	CbGeAlD
Irinotecan—ABCG2—saliva-secreting gland—thyroid cancer	0.000213	0.018	CbGeAlD
Irinotecan—CES2—lymph node—thyroid cancer	0.000206	0.0175	CbGeAlD
Irinotecan—ABCC1—trachea—thyroid cancer	0.000199	0.0168	CbGeAlD
Irinotecan—SLC22A3—thyroid gland—thyroid cancer	0.00019	0.0161	CbGeAlD
Irinotecan—BCHE—trachea—thyroid cancer	0.00017	0.0144	CbGeAlD
Irinotecan—CES1—lymph node—thyroid cancer	0.00017	0.0144	CbGeAlD
Irinotecan—ACHE—lymph node—thyroid cancer	0.00017	0.0144	CbGeAlD
Irinotecan—SLC22A3—head—thyroid cancer	0.000169	0.0143	CbGeAlD
Irinotecan—ABCC1—thyroid gland—thyroid cancer	0.000157	0.0133	CbGeAlD
Irinotecan—BCHE—thyroid gland—thyroid cancer	0.000135	0.0114	CbGeAlD
Irinotecan—ABCG2—thyroid gland—thyroid cancer	0.00013	0.011	CbGeAlD
Irinotecan—BCHE—head—thyroid cancer	0.000119	0.0101	CbGeAlD
Irinotecan—ALB—lymph node—thyroid cancer	0.000118	0.01	CbGeAlD
Irinotecan—SLC22A3—lymph node—thyroid cancer	0.000118	0.00998	CbGeAlD
Irinotecan—ABCC2—lymph node—thyroid cancer	0.000111	0.00937	CbGeAlD
Irinotecan—CYP2B6—head—thyroid cancer	0.000106	0.009	CbGeAlD
Irinotecan—Vasodilation—Epirubicin—thyroid cancer	0.000104	0.00228	CcSEcCtD
Irinotecan—Vasodilation procedure—Epirubicin—thyroid cancer	0.000104	0.00228	CcSEcCtD
Irinotecan—Muscle spasms—Sorafenib—thyroid cancer	0.000104	0.00228	CcSEcCtD
Irinotecan—Abdominal pain—Vandetanib—thyroid cancer	0.000103	0.00227	CcSEcCtD
Irinotecan—Body temperature increased—Vandetanib—thyroid cancer	0.000103	0.00227	CcSEcCtD
Irinotecan—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.0001	0.00221	CcSEcCtD
Irinotecan—Anaemia—Sorafenib—thyroid cancer	9.96e-05	0.00219	CcSEcCtD
Irinotecan—Cough increased—Epirubicin—thyroid cancer	9.95e-05	0.00219	CcSEcCtD
Irinotecan—Lacrimation increased—Epirubicin—thyroid cancer	9.88e-05	0.00218	CcSEcCtD
Irinotecan—Neoplasm malignant—Doxorubicin—thyroid cancer	9.87e-05	0.00217	CcSEcCtD
Irinotecan—ABCC1—lymph node—thyroid cancer	9.76e-05	0.00825	CbGeAlD
Irinotecan—Syncope—Sorafenib—thyroid cancer	9.66e-05	0.00213	CcSEcCtD
Irinotecan—Extravasation—Doxorubicin—thyroid cancer	9.66e-05	0.00213	CcSEcCtD
Irinotecan—Leukopenia—Sorafenib—thyroid cancer	9.64e-05	0.00213	CcSEcCtD
Irinotecan—Blood bilirubin increased—Epirubicin—thyroid cancer	9.63e-05	0.00212	CcSEcCtD
Irinotecan—Dysarthria—Epirubicin—thyroid cancer	9.63e-05	0.00212	CcSEcCtD
Irinotecan—Ulcer—Epirubicin—thyroid cancer	9.63e-05	0.00212	CcSEcCtD
Irinotecan—Vasodilation—Doxorubicin—thyroid cancer	9.59e-05	0.00211	CcSEcCtD
Irinotecan—Vasodilation procedure—Doxorubicin—thyroid cancer	9.59e-05	0.00211	CcSEcCtD
Irinotecan—Loss of consciousness—Sorafenib—thyroid cancer	9.47e-05	0.00209	CcSEcCtD
Irinotecan—Cough—Sorafenib—thyroid cancer	9.4e-05	0.00207	CcSEcCtD
Irinotecan—Asthenia—Vandetanib—thyroid cancer	9.35e-05	0.00206	CcSEcCtD
Irinotecan—Gait disturbance—Epirubicin—thyroid cancer	9.33e-05	0.00206	CcSEcCtD
Irinotecan—Hypertension—Sorafenib—thyroid cancer	9.3e-05	0.00205	CcSEcCtD
Irinotecan—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	9.27e-05	0.00204	CcSEcCtD
Irinotecan—Cough increased—Doxorubicin—thyroid cancer	9.2e-05	0.00203	CcSEcCtD
Irinotecan—Lacrimation increased—Doxorubicin—thyroid cancer	9.14e-05	0.00202	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Epirubicin—thyroid cancer	9.11e-05	0.00201	CcSEcCtD
Irinotecan—Hiccups—Epirubicin—thyroid cancer	9.11e-05	0.00201	CcSEcCtD
Irinotecan—Pulmonary embolism—Epirubicin—thyroid cancer	9.11e-05	0.00201	CcSEcCtD
Irinotecan—Diarrhoea—Vandetanib—thyroid cancer	8.92e-05	0.00197	CcSEcCtD
Irinotecan—Blood bilirubin increased—Doxorubicin—thyroid cancer	8.91e-05	0.00196	CcSEcCtD
Irinotecan—Dysarthria—Doxorubicin—thyroid cancer	8.91e-05	0.00196	CcSEcCtD
Irinotecan—Ulcer—Doxorubicin—thyroid cancer	8.91e-05	0.00196	CcSEcCtD
Irinotecan—Salivary hypersecretion—Epirubicin—thyroid cancer	8.84e-05	0.00195	CcSEcCtD
Irinotecan—Anaphylactic shock—Sorafenib—thyroid cancer	8.79e-05	0.00194	CcSEcCtD
Irinotecan—Colitis—Epirubicin—thyroid cancer	8.74e-05	0.00193	CcSEcCtD
Irinotecan—Infection—Sorafenib—thyroid cancer	8.73e-05	0.00193	CcSEcCtD
Irinotecan—Shock—Sorafenib—thyroid cancer	8.65e-05	0.00191	CcSEcCtD
Irinotecan—Gait disturbance—Doxorubicin—thyroid cancer	8.63e-05	0.0019	CcSEcCtD
Irinotecan—Nervous system disorder—Sorafenib—thyroid cancer	8.62e-05	0.0019	CcSEcCtD
Irinotecan—Dizziness—Vandetanib—thyroid cancer	8.62e-05	0.0019	CcSEcCtD
Irinotecan—Thrombocytopenia—Sorafenib—thyroid cancer	8.61e-05	0.0019	CcSEcCtD
Irinotecan—Pulmonary embolism—Doxorubicin—thyroid cancer	8.43e-05	0.00186	CcSEcCtD
Irinotecan—Hiccups—Doxorubicin—thyroid cancer	8.43e-05	0.00186	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	8.43e-05	0.00186	CcSEcCtD
Irinotecan—Anorexia—Sorafenib—thyroid cancer	8.38e-05	0.00185	CcSEcCtD
Irinotecan—BCHE—lymph node—thyroid cancer	8.36e-05	0.00707	CbGeAlD
Irinotecan—Vomiting—Vandetanib—thyroid cancer	8.29e-05	0.00183	CcSEcCtD
Irinotecan—Neoplasm—Epirubicin—thyroid cancer	8.23e-05	0.00181	CcSEcCtD
Irinotecan—Rash—Vandetanib—thyroid cancer	8.22e-05	0.00181	CcSEcCtD
Irinotecan—Dermatitis—Vandetanib—thyroid cancer	8.21e-05	0.00181	CcSEcCtD
Irinotecan—Salivary hypersecretion—Doxorubicin—thyroid cancer	8.18e-05	0.0018	CcSEcCtD
Irinotecan—Headache—Vandetanib—thyroid cancer	8.17e-05	0.0018	CcSEcCtD
Irinotecan—ABCB1—trachea—thyroid cancer	8.1e-05	0.00686	CbGeAlD
Irinotecan—Colitis—Doxorubicin—thyroid cancer	8.09e-05	0.00178	CcSEcCtD
Irinotecan—ABCG2—lymph node—thyroid cancer	8.08e-05	0.00683	CbGeAlD
Irinotecan—Sepsis—Epirubicin—thyroid cancer	7.9e-05	0.00174	CcSEcCtD
Irinotecan—Dyspnoea—Sorafenib—thyroid cancer	7.84e-05	0.00173	CcSEcCtD
Irinotecan—Nausea—Vandetanib—thyroid cancer	7.74e-05	0.00171	CcSEcCtD
Irinotecan—Dyspepsia—Sorafenib—thyroid cancer	7.74e-05	0.00171	CcSEcCtD
Irinotecan—Decreased appetite—Sorafenib—thyroid cancer	7.64e-05	0.00168	CcSEcCtD
Irinotecan—Thrombophlebitis—Epirubicin—thyroid cancer	7.64e-05	0.00168	CcSEcCtD
Irinotecan—Neoplasm—Doxorubicin—thyroid cancer	7.62e-05	0.00168	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	7.6e-05	0.00168	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Sorafenib—thyroid cancer	7.59e-05	0.00167	CcSEcCtD
Irinotecan—Fatigue—Sorafenib—thyroid cancer	7.58e-05	0.00167	CcSEcCtD
Irinotecan—Constipation—Sorafenib—thyroid cancer	7.52e-05	0.00166	CcSEcCtD
Irinotecan—Pain—Sorafenib—thyroid cancer	7.52e-05	0.00166	CcSEcCtD
Irinotecan—Sepsis—Doxorubicin—thyroid cancer	7.31e-05	0.00161	CcSEcCtD
Irinotecan—Gastrointestinal pain—Sorafenib—thyroid cancer	7.19e-05	0.00158	CcSEcCtD
Irinotecan—Renal failure acute—Epirubicin—thyroid cancer	7.16e-05	0.00158	CcSEcCtD
Irinotecan—Thrombophlebitis—Doxorubicin—thyroid cancer	7.07e-05	0.00156	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	7.03e-05	0.00155	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Epirubicin—thyroid cancer	7.01e-05	0.00154	CcSEcCtD
Irinotecan—Abdominal pain—Sorafenib—thyroid cancer	6.95e-05	0.00153	CcSEcCtD
Irinotecan—Body temperature increased—Sorafenib—thyroid cancer	6.95e-05	0.00153	CcSEcCtD
Irinotecan—Renal impairment—Epirubicin—thyroid cancer	6.95e-05	0.00153	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Epirubicin—thyroid cancer	6.83e-05	0.00151	CcSEcCtD
Irinotecan—Cerebrovascular accident—Epirubicin—thyroid cancer	6.75e-05	0.00149	CcSEcCtD
Irinotecan—Hyponatraemia—Epirubicin—thyroid cancer	6.64e-05	0.00146	CcSEcCtD
Irinotecan—Renal failure acute—Doxorubicin—thyroid cancer	6.63e-05	0.00146	CcSEcCtD
Irinotecan—Osteoarthritis—Epirubicin—thyroid cancer	6.61e-05	0.00146	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	6.61e-05	0.00146	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Doxorubicin—thyroid cancer	6.48e-05	0.00143	CcSEcCtD
Irinotecan—Hypersensitivity—Sorafenib—thyroid cancer	6.48e-05	0.00143	CcSEcCtD
Irinotecan—Renal impairment—Doxorubicin—thyroid cancer	6.43e-05	0.00142	CcSEcCtD
Irinotecan—ABCB1—thyroid gland—thyroid cancer	6.41e-05	0.00542	CbGeAlD
Irinotecan—Anaphylactoid reaction—Doxorubicin—thyroid cancer	6.32e-05	0.00139	CcSEcCtD
Irinotecan—Asthenia—Sorafenib—thyroid cancer	6.31e-05	0.00139	CcSEcCtD
Irinotecan—Cardiac arrest—Epirubicin—thyroid cancer	6.29e-05	0.00139	CcSEcCtD
Irinotecan—Cerebrovascular accident—Doxorubicin—thyroid cancer	6.24e-05	0.00138	CcSEcCtD
Irinotecan—Blood creatinine increased—Epirubicin—thyroid cancer	6.19e-05	0.00136	CcSEcCtD
Irinotecan—Dehydration—Epirubicin—thyroid cancer	6.15e-05	0.00136	CcSEcCtD
Irinotecan—Hyponatraemia—Doxorubicin—thyroid cancer	6.14e-05	0.00135	CcSEcCtD
Irinotecan—Osteoarthritis—Doxorubicin—thyroid cancer	6.12e-05	0.00135	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	6.12e-05	0.00135	CcSEcCtD
Irinotecan—Orthostatic hypotension—Epirubicin—thyroid cancer	6.04e-05	0.00133	CcSEcCtD
Irinotecan—Hypokalaemia—Epirubicin—thyroid cancer	6.02e-05	0.00133	CcSEcCtD
Irinotecan—Diarrhoea—Sorafenib—thyroid cancer	6.02e-05	0.00133	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	5.95e-05	0.00131	CcSEcCtD
Irinotecan—Cardiac arrest—Doxorubicin—thyroid cancer	5.82e-05	0.00128	CcSEcCtD
Irinotecan—Dizziness—Sorafenib—thyroid cancer	5.81e-05	0.00128	CcSEcCtD
Irinotecan—Abdominal distension—Epirubicin—thyroid cancer	5.75e-05	0.00127	CcSEcCtD
Irinotecan—Blood creatinine increased—Doxorubicin—thyroid cancer	5.73e-05	0.00126	CcSEcCtD
Irinotecan—Dehydration—Doxorubicin—thyroid cancer	5.69e-05	0.00125	CcSEcCtD
Irinotecan—ABCB1—head—thyroid cancer	5.69e-05	0.00481	CbGeAlD
Irinotecan—Pancreatitis—Epirubicin—thyroid cancer	5.6e-05	0.00123	CcSEcCtD
Irinotecan—Vomiting—Sorafenib—thyroid cancer	5.59e-05	0.00123	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—thyroid cancer	5.59e-05	0.00123	CcSEcCtD
Irinotecan—Hypokalaemia—Doxorubicin—thyroid cancer	5.57e-05	0.00123	CcSEcCtD
Irinotecan—Angina pectoris—Epirubicin—thyroid cancer	5.57e-05	0.00123	CcSEcCtD
Irinotecan—Rash—Sorafenib—thyroid cancer	5.54e-05	0.00122	CcSEcCtD
Irinotecan—Dermatitis—Sorafenib—thyroid cancer	5.54e-05	0.00122	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	5.51e-05	0.00121	CcSEcCtD
Irinotecan—Headache—Sorafenib—thyroid cancer	5.51e-05	0.00121	CcSEcCtD
Irinotecan—Neutropenia—Epirubicin—thyroid cancer	5.34e-05	0.00118	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—thyroid cancer	5.32e-05	0.00117	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Epirubicin—thyroid cancer	5.31e-05	0.00117	CcSEcCtD
Irinotecan—Nausea—Sorafenib—thyroid cancer	5.22e-05	0.00115	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—thyroid cancer	5.18e-05	0.00114	CcSEcCtD
Irinotecan—Weight decreased—Epirubicin—thyroid cancer	5.17e-05	0.00114	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—thyroid cancer	5.15e-05	0.00114	CcSEcCtD
Irinotecan—Pneumonia—Epirubicin—thyroid cancer	5.12e-05	0.00113	CcSEcCtD
Irinotecan—Renal failure—Epirubicin—thyroid cancer	5.01e-05	0.0011	CcSEcCtD
Irinotecan—Stomatitis—Epirubicin—thyroid cancer	4.97e-05	0.00109	CcSEcCtD
Irinotecan—Jaundice—Epirubicin—thyroid cancer	4.97e-05	0.00109	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—thyroid cancer	4.94e-05	0.00109	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—thyroid cancer	4.91e-05	0.00108	CcSEcCtD
Irinotecan—Sweating—Epirubicin—thyroid cancer	4.88e-05	0.00108	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—thyroid cancer	4.78e-05	0.00105	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—thyroid cancer	4.74e-05	0.00104	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—thyroid cancer	4.66e-05	0.00103	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—thyroid cancer	4.63e-05	0.00102	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—thyroid cancer	4.6e-05	0.00101	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—thyroid cancer	4.59e-05	0.00101	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—thyroid cancer	4.59e-05	0.00101	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—thyroid cancer	4.59e-05	0.00101	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—thyroid cancer	4.57e-05	0.00101	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—thyroid cancer	4.52e-05	0.000996	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—thyroid cancer	4.49e-05	0.000991	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—thyroid cancer	4.41e-05	0.000971	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—thyroid cancer	4.31e-05	0.000949	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—thyroid cancer	4.25e-05	0.000937	CcSEcCtD
Irinotecan—Flushing—Epirubicin—thyroid cancer	4.24e-05	0.000935	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—thyroid cancer	4.24e-05	0.000935	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—thyroid cancer	4.24e-05	0.000935	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—thyroid cancer	4.23e-05	0.000933	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—thyroid cancer	4.16e-05	0.000917	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—thyroid cancer	4.15e-05	0.000915	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—thyroid cancer	4.13e-05	0.00091	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—thyroid cancer	4.12e-05	0.000908	CcSEcCtD
Irinotecan—Chills—Epirubicin—thyroid cancer	4.1e-05	0.000904	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—thyroid cancer	4.09e-05	0.0009	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—thyroid cancer	4.08e-05	0.000899	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—thyroid cancer	4.04e-05	0.000891	CcSEcCtD
Irinotecan—ABCB1—lymph node—thyroid cancer	3.98e-05	0.00337	CbGeAlD
Irinotecan—Flushing—Doxorubicin—thyroid cancer	3.93e-05	0.000866	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—thyroid cancer	3.93e-05	0.000866	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—thyroid cancer	3.92e-05	0.000865	CcSEcCtD
Irinotecan—Back pain—Epirubicin—thyroid cancer	3.85e-05	0.000849	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—thyroid cancer	3.84e-05	0.000846	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—thyroid cancer	3.83e-05	0.000844	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—thyroid cancer	3.82e-05	0.000842	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—thyroid cancer	3.81e-05	0.000841	CcSEcCtD
Irinotecan—Chills—Doxorubicin—thyroid cancer	3.8e-05	0.000837	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—thyroid cancer	3.78e-05	0.000833	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—thyroid cancer	3.74e-05	0.000824	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—thyroid cancer	3.69e-05	0.000814	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—thyroid cancer	3.68e-05	0.000811	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—thyroid cancer	3.63e-05	0.0008	CcSEcCtD
Irinotecan—Malaise—Epirubicin—thyroid cancer	3.59e-05	0.000791	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—thyroid cancer	3.58e-05	0.000788	CcSEcCtD
Irinotecan—Syncope—Epirubicin—thyroid cancer	3.57e-05	0.000787	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—thyroid cancer	3.56e-05	0.000785	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—thyroid cancer	3.56e-05	0.000785	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—thyroid cancer	3.54e-05	0.000781	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—thyroid cancer	3.5e-05	0.000771	CcSEcCtD
Irinotecan—Cough—Epirubicin—thyroid cancer	3.47e-05	0.000766	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—thyroid cancer	3.44e-05	0.000758	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—thyroid cancer	3.42e-05	0.000753	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—thyroid cancer	3.4e-05	0.00075	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—thyroid cancer	3.35e-05	0.000738	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—thyroid cancer	3.32e-05	0.000732	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—thyroid cancer	3.31e-05	0.000729	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—thyroid cancer	3.3e-05	0.000728	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—thyroid cancer	3.3e-05	0.000727	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—thyroid cancer	3.28e-05	0.000722	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—thyroid cancer	3.25e-05	0.000716	CcSEcCtD
Irinotecan—Oedema—Epirubicin—thyroid cancer	3.25e-05	0.000716	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—thyroid cancer	3.24e-05	0.000714	CcSEcCtD
Irinotecan—Infection—Epirubicin—thyroid cancer	3.23e-05	0.000711	CcSEcCtD
Irinotecan—Cough—Doxorubicin—thyroid cancer	3.21e-05	0.000708	CcSEcCtD
Irinotecan—Shock—Epirubicin—thyroid cancer	3.2e-05	0.000705	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—thyroid cancer	3.19e-05	0.000702	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—thyroid cancer	3.18e-05	0.000701	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—thyroid cancer	3.18e-05	0.000701	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—thyroid cancer	3.14e-05	0.000692	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—thyroid cancer	3.1e-05	0.000683	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—thyroid cancer	3.1e-05	0.000683	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—thyroid cancer	3.04e-05	0.000669	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—thyroid cancer	3.03e-05	0.000668	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—thyroid cancer	3.01e-05	0.000663	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—thyroid cancer	3.01e-05	0.000663	CcSEcCtD
Irinotecan—Infection—Doxorubicin—thyroid cancer	2.99e-05	0.000658	CcSEcCtD
Irinotecan—Shock—Doxorubicin—thyroid cancer	2.96e-05	0.000652	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—thyroid cancer	2.95e-05	0.00065	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—thyroid cancer	2.94e-05	0.000649	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—thyroid cancer	2.94e-05	0.000648	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—thyroid cancer	2.92e-05	0.000643	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—thyroid cancer	2.91e-05	0.000641	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—thyroid cancer	2.9e-05	0.000638	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—thyroid cancer	2.89e-05	0.000637	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—thyroid cancer	2.87e-05	0.000632	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—thyroid cancer	2.86e-05	0.00063	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—thyroid cancer	2.82e-05	0.000623	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—thyroid cancer	2.81e-05	0.000619	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—thyroid cancer	2.81e-05	0.000618	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—thyroid cancer	2.8e-05	0.000617	CcSEcCtD
Irinotecan—Pain—Epirubicin—thyroid cancer	2.78e-05	0.000612	CcSEcCtD
Irinotecan—Constipation—Epirubicin—thyroid cancer	2.78e-05	0.000612	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—thyroid cancer	2.72e-05	0.000599	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—thyroid cancer	2.7e-05	0.000595	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—thyroid cancer	2.68e-05	0.000591	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—thyroid cancer	2.68e-05	0.00059	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—thyroid cancer	2.67e-05	0.000589	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—thyroid cancer	2.66e-05	0.000586	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—thyroid cancer	2.65e-05	0.000583	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—thyroid cancer	2.61e-05	0.000576	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—thyroid cancer	2.6e-05	0.000572	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—thyroid cancer	2.59e-05	0.000571	CcSEcCtD
Irinotecan—Pain—Doxorubicin—thyroid cancer	2.57e-05	0.000567	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—thyroid cancer	2.57e-05	0.000567	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—thyroid cancer	2.57e-05	0.000566	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—thyroid cancer	2.57e-05	0.000566	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—thyroid cancer	2.48e-05	0.000546	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—thyroid cancer	2.46e-05	0.000542	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—thyroid cancer	2.39e-05	0.000528	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—thyroid cancer	2.38e-05	0.000524	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—thyroid cancer	2.38e-05	0.000524	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—thyroid cancer	2.33e-05	0.000514	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—thyroid cancer	2.22e-05	0.00049	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—thyroid cancer	2.22e-05	0.000488	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—thyroid cancer	2.16e-05	0.000475	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—thyroid cancer	2.15e-05	0.000474	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—thyroid cancer	2.07e-05	0.000455	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—thyroid cancer	2.06e-05	0.000453	CcSEcCtD
Irinotecan—Rash—Epirubicin—thyroid cancer	2.05e-05	0.000452	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—thyroid cancer	2.05e-05	0.000451	CcSEcCtD
Irinotecan—Headache—Epirubicin—thyroid cancer	2.04e-05	0.000449	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—thyroid cancer	1.99e-05	0.000438	CcSEcCtD
Irinotecan—Nausea—Epirubicin—thyroid cancer	1.93e-05	0.000425	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—thyroid cancer	1.91e-05	0.000421	CcSEcCtD
Irinotecan—Rash—Doxorubicin—thyroid cancer	1.9e-05	0.000418	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—thyroid cancer	1.89e-05	0.000417	CcSEcCtD
Irinotecan—Headache—Doxorubicin—thyroid cancer	1.88e-05	0.000415	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—thyroid cancer	1.79e-05	0.000394	CcSEcCtD
Irinotecan—BCHE—Metabolism—CHST14—thyroid cancer	1.22e-05	0.00161	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.22e-05	0.00161	CbGpPWpGaD
Irinotecan—ACHE—Phospholipid metabolism—PTEN—thyroid cancer	1.21e-05	0.00159	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CHST14—thyroid cancer	1.19e-05	0.00157	CbGpPWpGaD
Irinotecan—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.18e-05	0.00155	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.18e-05	0.00155	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	1.18e-05	0.00155	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NDUFA13—thyroid cancer	1.17e-05	0.00155	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NDUFA13—thyroid cancer	1.16e-05	0.00153	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.16e-05	0.00153	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.14e-05	0.00149	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—HPGD—thyroid cancer	1.11e-05	0.00146	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CHST14—thyroid cancer	1.1e-05	0.00145	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CHST14—thyroid cancer	1.09e-05	0.00144	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.09e-05	0.00144	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	1.09e-05	0.00144	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.08e-05	0.00143	CbGpPWpGaD
Irinotecan—BCHE—Phospholipid metabolism—PTEN—thyroid cancer	1.08e-05	0.00142	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.07e-05	0.00141	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.07e-05	0.0014	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—HPGD—thyroid cancer	1.05e-05	0.00138	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—HPGD—thyroid cancer	1.05e-05	0.00138	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MINPP1—thyroid cancer	1.01e-05	0.00133	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—HPGD—thyroid cancer	1.01e-05	0.00133	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.01e-05	0.00133	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	9.92e-06	0.00131	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MINPP1—thyroid cancer	9.9e-06	0.0013	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—HPGD—thyroid cancer	9.86e-06	0.0013	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	9.85e-06	0.0013	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—BRAF—thyroid cancer	9.75e-06	0.00128	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.64e-06	0.00127	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—HPGD—thyroid cancer	9.61e-06	0.00127	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TCF7L1—thyroid cancer	9.48e-06	0.00125	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.4e-06	0.00124	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	9.35e-06	0.00123	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.3e-06	0.00122	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.29e-06	0.00122	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.97e-06	0.00118	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—HPGD—thyroid cancer	8.9e-06	0.00117	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.83e-06	0.00116	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—HPGD—thyroid cancer	8.82e-06	0.00116	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—BRAF—thyroid cancer	8.7e-06	0.00115	CbGpPWpGaD
Irinotecan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	8.62e-06	0.00113	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NDUFA13—thyroid cancer	8.61e-06	0.00113	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MINPP1—thyroid cancer	8.52e-06	0.00112	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.51e-06	0.00112	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NDUFA13—thyroid cancer	8.42e-06	0.00111	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.21e-06	0.00108	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.17e-06	0.00108	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CHST14—thyroid cancer	8.1e-06	0.00107	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—TPR—thyroid cancer	8.07e-06	0.00106	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8e-06	0.00105	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	7.94e-06	0.00104	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CHST14—thyroid cancer	7.91e-06	0.00104	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.9e-06	0.00104	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.8e-06	0.00103	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.8e-06	0.00103	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PRKAR1A—thyroid cancer	7.66e-06	0.00101	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MINPP1—thyroid cancer	7.47e-06	0.000983	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.42e-06	0.000976	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—thyroid cancer	7.38e-06	0.000972	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NDUFA13—thyroid cancer	7.25e-06	0.000954	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.14e-06	0.00094	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TPR—thyroid cancer	6.94e-06	0.000913	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.87e-06	0.000904	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PRKAR1A—thyroid cancer	6.83e-06	0.000899	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CHST14—thyroid cancer	6.82e-06	0.000897	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	6.74e-06	0.000887	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	6.74e-06	0.000887	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.63e-06	0.000872	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—HPGD—thyroid cancer	6.53e-06	0.000859	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MEN1—thyroid cancer	6.52e-06	0.000859	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HPGD—thyroid cancer	6.38e-06	0.00084	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TPR—thyroid cancer	6.35e-06	0.000836	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NDUFA13—thyroid cancer	6.35e-06	0.000836	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.35e-06	0.000836	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.26e-06	0.000825	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PRKAR1A—thyroid cancer	6.25e-06	0.000822	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—SLC5A5—thyroid cancer	6.04e-06	0.000795	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TPR—thyroid cancer	6.03e-06	0.000793	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TPR—thyroid cancer	6.03e-06	0.000793	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CHST14—thyroid cancer	5.97e-06	0.000786	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	5.93e-06	0.00078	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	5.93e-06	0.00078	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	5.9e-06	0.000777	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.9e-06	0.000777	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.85e-06	0.00077	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TPR—thyroid cancer	5.81e-06	0.000765	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.81e-06	0.000764	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PRKAR1A—thyroid cancer	5.72e-06	0.000752	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TPR—thyroid cancer	5.67e-06	0.000746	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.66e-06	0.000745	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PRKAR1A—thyroid cancer	5.57e-06	0.000734	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TPR—thyroid cancer	5.52e-06	0.000727	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HPGD—thyroid cancer	5.49e-06	0.000723	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.46e-06	0.000719	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	5.43e-06	0.000715	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.37e-06	0.000707	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.36e-06	0.000706	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.22e-06	0.000687	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CALCA—thyroid cancer	5.19e-06	0.000684	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.18e-06	0.000682	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TPR—thyroid cancer	5.11e-06	0.000673	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—RXRA—thyroid cancer	5.07e-06	0.000668	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IFNA2—thyroid cancer	5.07e-06	0.000668	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TPR—thyroid cancer	5.07e-06	0.000667	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.05e-06	0.000665	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.04e-06	0.000664	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PRKAR1A—thyroid cancer	5.03e-06	0.000662	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	4.99e-06	0.000656	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.92e-06	0.000648	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HPGD—thyroid cancer	4.81e-06	0.000634	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—SLC5A5—thyroid cancer	4.75e-06	0.000626	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDK1—thyroid cancer	4.7e-06	0.000619	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.64e-06	0.000611	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.6e-06	0.000606	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—SLC5A5—thyroid cancer	4.51e-06	0.000594	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—SLC5A5—thyroid cancer	4.51e-06	0.000594	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—thyroid cancer	4.48e-06	0.00059	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.46e-06	0.000587	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.46e-06	0.000586	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.42e-06	0.000582	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SLC5A5—thyroid cancer	4.35e-06	0.000573	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SLC5A5—thyroid cancer	4.24e-06	0.000558	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.24e-06	0.000558	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.23e-06	0.000556	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.2e-06	0.000552	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	4.13e-06	0.000544	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.08e-06	0.000537	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.05e-06	0.000533	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—thyroid cancer	4e-06	0.000527	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—RXRA—thyroid cancer	3.99e-06	0.000526	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.97e-06	0.000523	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.91e-06	0.000515	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.89e-06	0.000511	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.87e-06	0.00051	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC5A5—thyroid cancer	3.83e-06	0.000504	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.79e-06	0.000499	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—RXRA—thyroid cancer	3.79e-06	0.000499	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—RXRA—thyroid cancer	3.79e-06	0.000499	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRG1—thyroid cancer	3.77e-06	0.000497	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TPR—thyroid cancer	3.75e-06	0.000493	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.71e-06	0.000489	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	3.69e-06	0.000485	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.69e-06	0.000485	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CHST14—thyroid cancer	3.68e-06	0.000484	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TPR—thyroid cancer	3.66e-06	0.000482	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—RXRA—thyroid cancer	3.65e-06	0.000481	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.6e-06	0.000474	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—RXRA—thyroid cancer	3.56e-06	0.000469	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.55e-06	0.000468	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—RXRA—thyroid cancer	3.47e-06	0.000457	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.47e-06	0.000456	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TERT—thyroid cancer	3.39e-06	0.000446	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.38e-06	0.000445	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HIF1A—thyroid cancer	3.24e-06	0.000427	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—RXRA—thyroid cancer	3.22e-06	0.000423	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PPARG—thyroid cancer	3.2e-06	0.000422	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—RXRA—thyroid cancer	3.19e-06	0.00042	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TPR—thyroid cancer	3.16e-06	0.000415	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.11e-06	0.000409	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PRKAR1A—thyroid cancer	3.1e-06	0.000409	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HPGD—thyroid cancer	2.97e-06	0.00039	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.81e-06	0.00037	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC5A5—thyroid cancer	2.81e-06	0.000369	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TPR—thyroid cancer	2.76e-06	0.000364	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.76e-06	0.000364	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.74e-06	0.000361	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.72e-06	0.000358	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BRAF—thyroid cancer	2.68e-06	0.000353	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PPARG—thyroid cancer	2.52e-06	0.000332	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—thyroid cancer	2.52e-06	0.000332	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PPARG—thyroid cancer	2.39e-06	0.000315	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPARG—thyroid cancer	2.39e-06	0.000315	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.37e-06	0.000312	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC5A5—thyroid cancer	2.36e-06	0.000311	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—RXRA—thyroid cancer	2.36e-06	0.00031	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.33e-06	0.000307	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPARG—thyroid cancer	2.31e-06	0.000304	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—RXRA—thyroid cancer	2.3e-06	0.000303	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPARG—thyroid cancer	2.25e-06	0.000296	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.21e-06	0.000291	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—thyroid cancer	2.2e-06	0.000289	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPARG—thyroid cancer	2.19e-06	0.000289	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—thyroid cancer	2.17e-06	0.000285	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.07e-06	0.000272	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPARG—thyroid cancer	2.03e-06	0.000267	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPARG—thyroid cancer	2.01e-06	0.000265	CbGpPWpGaD
Irinotecan—ALB—Metabolism—RXRA—thyroid cancer	1.98e-06	0.000261	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—thyroid cancer	1.98e-06	0.000261	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.93e-06	0.000254	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—thyroid cancer	1.89e-06	0.000249	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—thyroid cancer	1.89e-06	0.000249	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.88e-06	0.000248	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.88e-06	0.000248	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—thyroid cancer	1.82e-06	0.000239	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—thyroid cancer	1.77e-06	0.000233	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—RXRA—thyroid cancer	1.74e-06	0.000229	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—thyroid cancer	1.73e-06	0.000228	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.73e-06	0.000227	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TPR—thyroid cancer	1.7e-06	0.000224	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—thyroid cancer	1.69e-06	0.000222	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.68e-06	0.000221	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—thyroid cancer	1.64e-06	0.000216	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—thyroid cancer	1.64e-06	0.000216	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—thyroid cancer	1.63e-06	0.000214	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—thyroid cancer	1.6e-06	0.00021	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.58e-06	0.000208	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—thyroid cancer	1.58e-06	0.000208	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—thyroid cancer	1.54e-06	0.000203	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.5e-06	0.000198	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARG—thyroid cancer	1.49e-06	0.000196	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARG—thyroid cancer	1.45e-06	0.000191	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—thyroid cancer	1.45e-06	0.000191	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—thyroid cancer	1.45e-06	0.00019	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—thyroid cancer	1.39e-06	0.000183	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—thyroid cancer	1.38e-06	0.000182	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—thyroid cancer	1.38e-06	0.000182	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.27e-06	0.000168	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—thyroid cancer	1.27e-06	0.000167	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARG—thyroid cancer	1.25e-06	0.000165	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—thyroid cancer	1.23e-06	0.000162	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—thyroid cancer	1.22e-06	0.000161	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.17e-06	0.000154	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.14e-06	0.000151	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARG—thyroid cancer	1.1e-06	0.000145	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—thyroid cancer	1.09e-06	0.000143	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RXRA—thyroid cancer	1.07e-06	0.000141	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—thyroid cancer	1.02e-06	0.000134	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—thyroid cancer	9.98e-07	0.000131	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—thyroid cancer	9.97e-07	0.000131	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—thyroid cancer	9.86e-07	0.00013	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—thyroid cancer	9.46e-07	0.000125	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—thyroid cancer	9.46e-07	0.000125	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—thyroid cancer	9.12e-07	0.00012	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—thyroid cancer	8.9e-07	0.000117	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—thyroid cancer	8.67e-07	0.000114	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—thyroid cancer	8.64e-07	0.000114	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—thyroid cancer	8.6e-07	0.000113	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—thyroid cancer	8.03e-07	0.000106	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—thyroid cancer	7.96e-07	0.000105	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—thyroid cancer	7.53e-07	9.91e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARG—thyroid cancer	6.76e-07	8.9e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—thyroid cancer	5.88e-07	7.75e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—thyroid cancer	5.75e-07	7.57e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.32e-07	7e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—thyroid cancer	4.95e-07	6.52e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—thyroid cancer	4.64e-07	6.11e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—thyroid cancer	4.34e-07	5.71e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—thyroid cancer	2.67e-07	3.52e-05	CbGpPWpGaD
